Abstract:Background In anaesthesiology, intrathecal drugs play pivotal roles in spinal anaesthesia. Despite their ability to induce a high sensory block, bupivacaine alone may not be adequate for postoperative analgesia. It often requires a substantial dose of postoperative rescue analgesia to manage pain effectively. Thus, we studied the efficacy of nalbuphine 1.5 mg injected intrathecally as an adjuvant in endoscopic urological surgery. Materials and methods Sixty patients undergoing endoscopic urological surgery were equally divided into two study groups: group B (injection 0.5% hyperbaric bupivacaine 15 mg (3 ml) plus sterile NS 0.15 ml) and group N (injection 0.5% hyperbaric bupivacaine 15 mg (3 ml)+nalbuphine 1.5 mg (0.15 ml)). The first appearance of the sensory and motor blockages and duration required to attain complete sensory and motor threshold was noted. All vitals were recorded. After surgery, it was recorded when the patient first needed rescue analgesia (injection paracetamol 1 gm IV). Any adverse effects were recorded and addressed. The statistical analysis was conducted using IBM SPSS Statistics for Windows, V. 22.0 (IBM Corp., Armonk, NY), with p<0.05 indicating significance in both groups' operations. Results Intrathecal nalbuphine as an adjuvant caused an earlier onset of sensory and motor inhibition, delayed two-segment regression, and prolonged postoperative anaesthesia. The control group experienced sensory block at 3.33±0.61 minutes, while the nalbuphine group had a mean onset of 2.66±0.92 minutes (p=0.001). The patient who received nalbuphine had a mean regression time of 119.60±14.549 minutes, whereas the bupivacaine group had a mean regression time of 88.43±17.196 minutes. Group N had a considerably longer duration of postoperative analgesia, lasting 264.97 minutes, compared to group B's 198.50 minutes (p<0.001). Intrathecal nalbuphine did not influence vital indicators such as heart rate, respiration rate, and oxygen saturation. Conclusion To conclude, endoscopic urological surgery patients who received a subarachnoid block with 1.5 mg (0.15 ml) of nalbuphine hydrochloride with 0.5% hyperbaric bupivacaine 15 mg (3 ml) had longer postoperative pain relief than those who received 3 ml of intrathecal bupivacaine (15 mg). Urinary retention and pruritus were absent. Intrathecal nalbuphine with hyperbaric 0.5% bupivacaine is deemed safe with minimal side effects in endoscopic urology surgery.

Extension Effect of Poly(Lactic-Co-Glycolic Acid)-Polyethylene Glycol Encapsulated Bupivacaine on Postoperative Neuroblockade in Cardiothoracic Surgery

Achieving Long-Acting Local Analgesia Using an Intelligent Hydrogel Encapsulated with Drug and Ph Regulator.

Precision-guided long-acting analgesia by Gel-immobilized bupivacaine-loaded microsphere.

Sustained Release of Levobupivacaine from Temperature-Sensitive Injectable Hydrogel for Long-Term Local Anesthesia in Postoperative Pain Management

Preparation and Investigation of A Novel Levobupivacaine in Situ Implant Gel for Prolonged Local Anesthetics

Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia

Extended Release of Bupivacaine from Temperature-responsive Hydrogels Provides Multi-day Analgesia for Postoperative Pain

Electrospun PLGA Nanomembrane: A Novel Formulation of Extended-Release Bupivacaine Delivery Reducing Postoperative Pain

An in Situ-Forming Phospholipid-Based Phase Transition Gel Prolongs the Duration of Local Anesthesia for Ropivacaine with Minimal Toxicity.

Long-acting Hydrogel/microsphere Composite Sequentially Releases Dexmedetomidine and Bupivacaine for Prolonged Synergistic Analgesia

A PLGA-PEG-PLGA Thermosensitive Gel Enabling Sustained Delivery of Ropivacaine Hydrochloride for Postoperative Pain Relief.

Long-Term Synergistic Analgesic Effect Analysis of Co-Delivery Bupivacaine and Dexmedetomidine Loaded by Nano Multilayer Liposome

Pre‐Clinical Assessment of Bupivacaine‐Loaded Poly(ester urea) Thin Films for Controlled Drug Release and Effective Pain Management After Surgery

Synthesis of nanocapsules blended polymeric hydrogel loaded with bupivacaine drug delivery system for local anesthetics and pain management

A new long-acting analgesic formulation for postoperative pain management

Exosomal Bupivacaine: Integrating Nerve Barrier Penetration Capability and Sustained Drug Release for Enhanced Potency in Peripheral Nerve Block and Reduced Toxicity

Construction of bupivacaine‐loaded gelatin‐based hydrogel delivery system for sciatic nerve block in mice

Prolonged Anesthesia Effects of Locally Administered Ropivacaine via Electrospun Poly(caprolactone) Fibrous Membranes

Assessment of the Efficacy of Nalbuphine as an Adjuvant to Intrathecal Bupivacaine in Endoscopic Urological Surgeries for the Prolongation of Postoperative Analgesia

Injectable Hydrogel Delivery System with High Drug Loading for Prolonging Local Anesthesia.

A hybrid nanoparticle-protein hydrogel system for prolonged local anesthesia